Cereona Partners provides capital formation and strategic advisory services to accelerate global health innovation
Growth Strategy & Capital Formation
Growth Strategy & Capital Formation
Our Services
Cereona Partners is uniquely positioned to liaise between funders, innovators, shareholders, and management.
We customize our services to meet your needs.
-
-
Narrative, numbers, & network
Pitch deck development
Fundraising process advisory
Warm investor network
-
We customize our services to meet your needs.
Client Results
Recent Transactions
Affect Therapeutics
Value: $26m Series B Fundraise
Announced: July 2025
Advisor to Affect Therapeutics on its new Series B investment led by Allumia Ventures, with participation from existing investors Artis Ventures, City Light Capital, and LifeArc Ventures, and new investor Limitless Ventures
Homethrive
Value: $20m+ Series C Fundraise
Announced: November 2024
Investor in Series C round led by TELUS Global Ventures and 7Wire Ventures, with participation from Pitango HealthTech, Human Capital, Outcomes Collective Growth Capital, Allianz, The K Fund, and other family offices.
Insights
About Cereona Partners
Cereona Partners provides capital formation and strategic advisory services to accelerate global health innovation.
We are partners who have sat in every seat—founder, funder, and builder. This perspective allows us to bridge worlds: we know when to operate within the system and when to take an outside view. Our approach combines creative capital strategy with enduring relationships across companies and investors who are determined to push healthcare forward. At our core, we believe innovation in healthcare is not just about advancing science—it’s about improving humanity.
The name Cereona merges Ceres, the Roman goddess of human flourishing, with Corona, the radiant halo of the sun visible only during an eclipse—the moment when what is normally unseen becomes illuminated. Together, they embody our mission: to illuminate and fund transformative ideas that shape the future of human health.
Team
-
Founder & CEO
Opal is the founder and CEO of Cereona Partners, a strategic advisory firm that bridges science, strategy, and capital to accelerate global health innovation. Opal is a FINRA-registered broker, and is conversational Gujarati, and Spanish. She holds an MBA from The Wharton School at the University of Pennsylvania, and proudly attended The Ohio State University for undergrad.
Past Experience
Leerink Partners – Head of middle market sponsor coverage
Novo Holdings – PE buyouts, pharma services and healthcare technology
Formation Bio – In-licensing and business development
Flatiron Health – Strategic partnerships and JVs
Roivant Sciences – In-licensing and commercial development
-
Partner, Venture Strategy
Adrianna is a Partner at Cereona Partners, where she helps translate complex science into scalable, investor-backed companies. She specializes in life sciences innovation across preventive health, precision medicine, and AI-driven platforms. Adrianna graduated from McGill University, and is near-native speaker in five languages: English, Portuguese, French, Spanish and, most importantly, Investor.
Past Experiencess
StrandSmart – Founder & CEO Stanford StartX
Qurasense – Co-founder and Bus Dev Lead (Y Combinator & Stanford StartX)
Sparkup – Co-founder, business development (acquired 2015)
-
Director, Operations
Sophia is the Director of Operations at Cereona Partners. She specializes in translating vision into systems that empower people and processes—aligning teams, removing friction, and creating clarity for scalable execution.
Past Experience
NMBL – Sr. Project Manager, Creative Ops
The Optimus Consultant Group – Director of Operations & HR
AI Acrobatics – Sr. Project Manager, AI Systems Design
Fenix Consulting Group – Sales & Leadership